R&D News | pharmaphorum

News

The unprecedented challenge of pricing a coronavirus vaccine

CureVac claims €75m in EU funding for mRNA COVID-19 vaccine

German vaccine firm CureVac has been awarded a €75 million loan from the European Investment Bank to boost its manufacturing capacity for its potential COVID-19 vaccine.

News

Idorsia on course to take on Eisai and Merck & Co after late...

Switzerland’s Idorsia says it is on course to file a potential next-generation insomnia drug around the end of this year after a second batch of supportive phase 3 trial results, although t

News

GSK and Sanofi close in on £500m COVID-19 vaccine deal with ...

GlaxoSmithKline and Sanofi are close to agreeing a £500m deal to supply the UK government with 60 million doses of their potential coroanvirus vaccine, according to a press report.

News

Blood sample with respiratory coronavirus positive

IL-6 hypothesis looking shaky as Kevzara fails COVID-19 tria...

Hopes that already-approved drugs targeting IL-6 could be repurposed to treat COVID-19 have been undermined by disappointing results from the first large-scale trial of Sanofi

News

Male Doctor In Office Working At Computer

Payments from UK pharma to healthcare professionals increase...

The UK’s pharmaceutical industry has published headline figures from its Disclosure UK scheme, showing payments from pharma to healthcare professionals increased in 2019.

News

Pfizer/BioNTech's COVID-19 vaccine neutralises virus in earl...

Pfizer and BioNTech have announced early results from their ongoing phase 1 /2 study of a potential COVID-19 coronavirus vaccine, showing the jab seems to be working in a small sample of pa

CureVac claims €75m in EU funding for mRNA COVID-19 vaccine

Idorsia on course to take on Eisai and Merck & Co after late...

GSK and Sanofi close in on £500m COVID-19 vaccine deal with ...

IL-6 hypothesis looking shaky as Kevzara fails COVID-19 tria...

Payments from UK pharma to healthcare professionals increase...

Pfizer/BioNTech's COVID-19 vaccine neutralises virus in earl...

Hengrui gets world-first okay for platelet drug hetrombopag

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks